Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate. (Q44061910)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate. |
scientific article |
Statements
Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate (English)
1 reference
Philadelphia chromosome
2 August 2024
Hagop M Kantarjian
Stefan Faderl
2 references
William Wierda
2 references
Susan O'Brien
2 references
Mary Beth Rios
2 references
Guillermo Garcia-Manero
2 references
Jorge E Cortes
2 references
Michael Keating
2 references
Jean-Pierre J Issa
Steven M Kornblau
Jianqin Shan
Sima Jeha
Moshe Talpaz
Francis J Giles
Debra Resta
Renaud Capdeville
Terry L Smith
Ying Yang
Deborah A Thomas